Ju‐Fang Liu
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 9
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 11
- Oncology top 5%
- Chemokine receptors and signaling 11
- Cytokine Signaling Pathways and Interactions 8
- Rheumatology top 5%
- Toxicology top 5%
-
- Cell death mechanisms and regulation 11
-
- Endoplasmic Reticulum Stress and Disease 9
-
- Autophagy in Disease and Therapy 9
-
- Cancer Mechanisms and Therapy 8
- Co-authors
- Chun‐Han HouChih‐Hsin TangChiang‐Wen LeePo‐Chun ChenYi‐Chin FongChin-Jung HsuSheng-Mou HouYao‐Chang Chiang
- Journals
- International Journal of Molecular Sciences (8 papers)The Journal of Infectious Diseases (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ju‐Fang Liu
81 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 419
- Immunology and Allergy 118
- Oncology 459
- Rheumatology 245
- Toxicology 53
Countries citing papers authored by Ju‐Fang Liu
This map shows the geographic impact of Ju‐Fang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Fang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Fang Liu more than expected).
Fields of papers citing papers by Ju‐Fang Liu
This network shows the impact of papers produced by Ju‐Fang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Fang Liu. The network helps show where Ju‐Fang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ju‐Fang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 14 | |
| 14 | 2020 | 17 | |
| 15 | 2018 | 69 | |
| 16 | 2014 | 109 | |
| 17 | 2012 | 38 | |
| 18 | 2012 | 18 | |
| 19 | 2012 | 32 | |
| 20 | 2010 | 10 |
About Ju‐Fang Liu
Ju‐Fang Liu is a scholar working on Immunology and Allergy, Cancer Research and Oncology, having authored 88 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Chemokine receptors and signaling (11 papers), Cell Adhesion Molecules Research (11 papers), Protease and Inhibitor Mechanisms (9 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Autophagy in Disease and Therapy (9 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Cancer Mechanisms and Therapy (8 papers). The work is most often cited by research in Cancer Research (419 citations), Immunology and Allergy (118 citations) and Oncology (459 citations). Ju‐Fang Liu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chun‐Han Hou, Chih‐Hsin Tang, Chiang‐Wen Lee, Po‐Chun Chen, Po‐Chun Chen, Yi‐Chin Fong, Chin-Jung Hsu, Sheng-Mou Hou, Yao‐Chang Chiang and Chih‐Yang Lin. Their work appears in journals such as International Journal of Molecular Sciences, The Journal of Infectious Diseases and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.